Factors associated with acute and late dysphagia in the DAHANCA 6 & 7 randomized trial with accelerated radiotherapy for head and neck cancer

Acta Oncologica

Volumn 52, Issue 7, 2013, Pages 1535-1542

  Mortensen, Hanna R ^a   Overgaard, Jens ^a   Jensen, Kenneth ^a   Specht, Lena ^b   Overgaard, Marie ^a   Johansen, Jorgen ^c   Evensen, Jan F ^d   Andersen, Elo ^e   Andersen, Lisbeth J ^f   Hansen, Hanne S ^g   Grau, Cai ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b University of Copenhagen   (Denmark)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^f AALBORG UNIVERSITY HOSPITAL   (Denmark)

^g FINSEN LABORATORY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

NIMORAZOLE; ANTINEOPLASTIC AGENT;

ACCELERATED RADIOTHERAPY; ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; DYSPHAGIA; FEMALE; FOLLOW UP; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT IDENTIFICATION; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE FRACTIONATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SCORING SYSTEM; STATISTICAL MODEL; ACUTE DYSPHAGIA; BODY SURFACE; CANCER CHEMOTHERAPY; CANCER GRADING; CONTROLLED STUDY; HEAD AND NECK CANCER; LATE DYSPHAGIA; MULTICENTER STUDY; NUTRITIONAL SUPPORT; PREVALENCE; PROSPECTIVE STUDY; RADIATION DOSE; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TUMOR LOCALIZATION;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; DEGLUTITION DISORDERS; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; RADIATION INJURIES; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RISK FACTORS; YOUNG ADULT;

EID: 84884539278     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2013.824609     Document Type: Article

References (30)

1. Mittal BB, Pauloski BR, Haraf DJ, Pelzer HJ, Argiris A, Vokes EE, et al. Swallowing dysfunction-preventative and rehabilitation strategies in patients with head-and-neck cancers treated with surgery, radiotherapy, and chemotherapy: A critical review. Int J Radiat Oncol Biol Phys 2003;57:1219-30
2. Logemann JA, Rademaker A W, Pauloski BR, Lazarus CL, Mittal BB, Brockstein B, et al. Site of disease and treatment protocol as correlates of swallowing function in patients with head and neck cancer treated with chemoradiation. Head Neck 2006;28:64-73
3. Overgaard J, Hansen H S, Specht L, Overgaard M, Grau C, Andersen E, et al. Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial. Lancet 2003;362:933-40
4. Langendijk JA, Doornaert P, Rietveld DH, VerdonckdEleeuw IM, Leemans CR, Slotman BJ. A predictive model for swallowing dysfunction after curative radiotherapy in head and neck cancer. Radiother Oncol 2009;90:189-95
5. Golen M, Skladowski K, Wygoda A, Przeorek W, Pilecki B, Maciejewski B, et al. A comparison of two scoring systems for late radiation toxicity in patients after radiotherapy for head and neck cancer. Reports Pract Oncol Radiother 2005;10:179-92
6. Mortensen HR, Jensen K, Grau C. A spiration pneumonia in patients treated with radiotherapy for head and neck cancer. Acta Oncol 2013;52:270-6
7. Jensen K, Bonde JA, Grau C. The relationship between observer-based toxicity scoring and patient assessed symptom severity after treatment for head and neck cancer. A correlative cross sectional study of the DAHANCA toxicity scoring system and the EORTC quality of life questionnaires . Radiother Oncol 2006;78:298-305
8. Koiwai K, Shikama N, Sasaki S, Shinoda A, Kadoya M. RIsk factors for severe dysphagia after concurrent chemoradiotherapy for head and neck cancers. Jpn J Clin Oncol 2009;39:413-7
9. Mangar S, Slevin N, Mais K, Sykes A. Evaluating predictive factors for determining enteral nutrition in patients receiving radical radiotherapy for head and neck cancer: A retrospective review. Radiother Oncol 2006;78:152-8
10. Poulsen MG, Riddle B, Keller J, Porceddu SV, Tripcony L. Predictors of acute grade 4 swallowing toxicity in patients with stages III anDiV squamous carcinoma of the head and neck treated with radiotherapy alone. Radiother Oncol 2008;87:253-9
11. Salama JK, Stenson KM, List MA, Mell LK, MacCracken E, Cohen EE, et al. Characteristics associated with swallowing changes after concurrent chemotherapy and radiotherapy in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 2008;134:1060-5
12. Nourissat A, Bairati I, Samson E, Fortin A, Gelinas M, Nabid A, et al. Predictors of weight loss during radiotherapy in patients with stage I or II head and neck cancer. Cancer 2010;116:2275-83
13. Ghadjar P, Simcock M, Zimmermann F, Betz M, Bodis S, Bernier J, et al. Predictors of severElate radiotherapy-related toxicity after hyperfractionated radiotherapy with or without concomitant cisplatin in locally advanced head and neck cancer. Secondary retrospective analysis of a randomized phase III trial (SAKK 10/94). Radiother Oncol 2012;104:213-8
14. Machtay M, Moughan J, Trotti A, Garden AS, Weber RS, Cooper JS, et al. Factors associated with severElate toxicity after concurrent chemoradiation for locally advanced head and neck cancer: An RTOG analysis. J Clin Oncol 2008;26:3582-9
15. Caudell J J, Schaner P E, Meredith R F, Locher J L, Nabell LM, Carroll WR, et al. Factors associated with longterm dysphagia after defi nitive radiotherapy for locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2009;73:410-5
16. Chen A M, Li BQ, Jennelle RL, Lau DH, Yang CC, Courquin J, et al. Late esophageal toxicity after radiation therapy for head and neck cancer. Head Neck 2010;32:178-83
17. Rutten H, Pop LA, Janssens GO, Takes RP, Knuijt S, Rooijakkers AF, et al. Long-term outcome and morbidity after treatment witHaccelerated radiotherapy and weekly cisplatin for locally advanced head-and-neck cancer: Results of a multidisciplinary late morbidity clinic. Int J Radiat Oncol Biol Phys 2011;81:923-9
18. Koiwai K, Shikama N, Sasaki S, Shinoda A, Kadoya M. Validation of the Total Dysphagia Risk Score (TDRS) as a predictive measure for acute swallowing dysfunction induced by chemoradiotherapy for head and neck cancers. Radiother Oncol 2010;97:132-5
19. Ottosson S, Zackrisson B, Kjellen E, Nilsson P, Laurell G. Weight loss in patients with head and neck cancer during and after conventional and accelerated radiotherapy. Acta Oncol 2013;52:711-8
20. Eisbruch A, Schwartz M, Rasch C, Vineberg K, Damen E, Van As CJ, et al. Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: WhicHanatomic structures are affected and can they be spared by IMRT? Int J Radiat Oncol Biol Phys 2004;60:1425-39
21. Bhide SA, Gulliford S, Kazi R, El-Hariry I, Newbold K, Harrington KJ, et al. Correlation between dose to the pharyngeal constrictors and patient quality of life and late dysphagiAfollowing chemo-IMRT for head and neck cancer. Radiother Oncol 2009;93:539-44
22. Caudell J J, Schaner P E, Desmond R A, Meredith R F, Spencer SA, Bonner JA. Dosimetric factors associated with long-term dysphagia after defi nitive radiotherapy for squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 2010;76:403-9
23. Jensen K, Lambertsen K, Grau C. Late swallowing dysfunction and dysphagia after radiotherapy for pharynx cancer: Frequency, intensity and correlation with dose and volume parameters. Radiother Oncol 2007;85:74-82
24. Sanguineti G, RaOn, Gunn B, Ricchetti F, Fiorino C. Predictors of PEG dependence after IMRT >/-chemotherapy for oropharyngeal cancer. Radiother Oncol 2013:107:300-4
25. Eisbruch A, Levendag PC, Feng FY, Teguh D, Lyden T, Schmitz PI, et al. Can IMRT or brachytherapy reduce dysphagia associated with chemoradiotherapy of head and neck cancer? The Michigan and Rotterdam experiences. Int J Radiat Oncol Biol Phys 2007;69:S40-2
26. Van Der Laan H P, Christianen M E, Bijl H P, Schilstra C, Langendijk JA. The potential benefi t of swallowing sparing intensity modulated radiotherapy to reduce swallowing dysfunction: An in silico planning comparative study. Radiother Oncol 2012;103:76-81
27. Van Der Laan HP, van de Water T A, van HerpThe, Christianen ME, Bijl HP, Korevaar EW, et al. The potentiaLof intensitymodulated proton radiotherapy to reduce swallowing dysfunction in the treatment of head and neck cancer: A planning comparative study. Acta Oncol 2013;52:561-9
28. Langendijk J A, Lambin P, De R D, Widder J, Bos M, Verheij M. Selection of patients for radiotherapy with protons aiming at reduction of side effects: The model-based approach. Radiother OncoLepub 2013:107:267-73
29. Van Der Laan H P, Gawryszuk A, Christianen ME, Steenbakkers RJ, Korevaar EW, Chouvalova O, et al. Swallowing-sparing intensity-modulated radiotherapy for head and neck cancer patients: Treatment planning optimization and clinicaLintroduction. Radiother OncoLepub 2013:107:282-7
30. Mortensen H R, Jensen K, Aksgl aDe K, Lambertsen K, Eriksen E, Grau C. Prophylactic systematic swallowing exercises in radical radiotherapy in head and neck cancer patients-a randomized trial. Submittet (in press